Abstract:Background Although type 1 diabetes (T1D) is typically described as a T cell-mediated autoimmune disease, increasing evidence for a role of B cells has emerged. However, the pivotal disease-relevant B cell subset and its contribution to islet autoimmunity remain elusive. Methods The frequencies and phenotypic characteristics of circulating B cell subsets were analyzed using flow cytometry in individuals with new-onset T1D, long-term T1D, type 2 diabetes, and nondiabetic controls, and also in a prospective cohort of patients receiving mesenchymal stromal cell (MSC) transplantation. NOD mice and adoptive transfer assay were used to dissect the role of the certain B cell subset in disease progression. An in-vitro coculture system of islets with immune cells was established to examine the response against islets and the underlying mechanisms. Results We identified that plasmablasts, a B cell subset at the antibody-secreting stage, were significantly increased and correlated with the deterioration of beta cell function in patients with new-onset T1D. Further, a fall of plasmablast number was associated with the preservation of beta cell function in patients who received MSC transplantation after 3 months of follow-up. Meanwhile, a gradual increase of plasmablasts in pancreatic lymph nodes during the natural progression of insulitis was observed in non-obese diabetic (NOD) mice; adoptive transfer of plasmablasts together with T cells from NOD mice accelerated diabetes onset in NOD/SCID recipients. Conclusions Our study revealed that plasmablasts may function as antigen-presenting cells and promote the activation and proinflammatory response of CD4 + T cells, further contributing to the T cell-mediated beta cell destruction. Our results provide insights into the pathogenic role of plasmablasts in islet autoimmunity and may offer new translational strategies for inhibiting T1D development.

Pancreatic draining lymph nodes (PLNs) serve as a pathogenic hub contributing to the development of type 1 diabetes

Expansion of Th17 Cells and Functional Defects in T Regulatory Cells Are Key Features of the Pancreatic Lymph Nodes in Patients With Type 1 Diabetes

Transcriptional Control of Pancreatic Β-Cell Identity and Plasticity During the Pathogenesis of Type 2 Diabetes.

The Contribution of Neutrophils and NETs to the Development of Type 1 Diabetes

Islet‐Resident Memory T Cells Orchestrate the Immunopathogenesis of Type 1 Diabetes through the FABP4‐CXCL10 Axis

Immune perturbations in human pancreas lymphatic tissues prior to and after type 1 diabetes onset

Role of the PD-1/PD-L1 Dyad in the Maintenance of Pancreatic Immune Tolerance for Prevention of Type 1 Diabetes

Revisiting the Antigen-Presenting Function of β Cells in T1D Pathogenesis

Lymphotoxins Serve as a Novel Orchestrator in T1D Pathogenesis

Aberrant TNF signaling in pancreatic lymph nodes of patients with Type 1 Diabetes

Innate Immunity in Type 1 Diabetes

The role of islet autoantigen-specific T cells in the onset and treatment of type 1 diabetes mellitus

Increased plasmablasts enhance T cell-mediated beta cell destruction and promote the development of type 1 diabetes

Advances in the Cellular Immunological Pathogenesis of Type 1 Diabetes.

Type 1 diabetes: immune pathology and novel therapeutic approaches

Elevated Glucose Metabolism Driving Pro-Inflammatory Response in B Cells Contributes to the Progression of Type 1 Diabetes.

Immune and Pancreatic β Cell Interactions in Type 1 Diabetes

Neutrophils in Type 1 Diabetes

Single-cell multi-omics analysis of human pancreatic islets reveals novel cellular states in type 1 diabetes

Neutrophil Extracellular Traps Caused by Gut Leakage Trigger the Autoimmune Response in Nonobese Diabetic Mice

PD-1/PD-L1 Inhibitory Pathway and Autoimmune Diabetes